Impact of CYP3A4 and CYP3A5 polymorphisms on tacrolimus dose requirements in Saudi kidney transplant patients

Marzog S. Al Nasser; Mai A. Alim A. Sattar Ahmad; Sherif Edris; Ezz Abdelfattah; Ahmed S. Ali; Mohammad F. Zaitoun; Futoon H. Alharbi; Hadiah B. Al Mahdi; Zoheir Damanhouri

doi:10.1007/s44446-025-00035-1

Citations

386

Views

Abstract not available for this publication.

Cite this Article (APA)

Marzog, S. A. N., Mai, A. A. A. S. A., Sherif, E., Ezz, A., Ahmed, S. A., Mohammad, F. Z., Futoon, H. A., Hadiah, B. A. M., Zoheir, D. (2025). Impact of CYP3A4 and CYP3A5 polymorphisms on tacrolimus dose requirements in Saudi kidney transplant patients. Saudi Pharmaceutical Journal. https://doi.org/10.1007/s44446-025-00035-1